Zobrazeno 1 - 10
of 47
pro vyhledávání: ''
Autor:
Annapaola Mariniello, Simona Carnio, Cristina Cecchi, Silvia Novello, Marco Donatello Delcuratolo
Publikováno v:
Clinical Lung Cancer. 22:e804-e807
Clinical Practice Points • Immune checkpoint inhibitors (ICIs) are associated with the development of unique immune-related adverse events (irAEs), which emerged primarily during post-marketing surveillance. Oral irAEs have already been reported, w
Autor:
Spencer Soberano, Elliot Charles Smith, Frances A. Shepherd, Prodipto Pal, Malcolm Ryan, Penelope A. Bradbury, Lisa W. Le, Kate M. Mackay, Ming-Sound Tsao, Natasha B. Leighl, Sze Wah Chan, Adrian G. Sacher, Geoffrey Liu, Aline Fusco Fares, S. Lau
Publikováno v:
Clinical Lung Cancer. 22:253-259
Introduction The efficacy of immune checkpoint inhibitors (ICIs) is low among EGFR-mutated non–small-cell lung cancer (NSCLC), although prolonged responses have occasionally been reported. We investigated the association between mutation subtypes a
Publikováno v:
Clinical Lung Cancer. 22:e301-e312
Background /Purpose: We report our clinical outcomes of patients with recurrent non-small cell lung cancer (NSCLC) tumors with ultra-central (UC) location treated with hypofractionated 10 fraction stereotactic body radiotherapy (hSBRT) in the context
Autor:
Hyo-Sun You, Hee-Taik Kang, Ye-Seul Kim, Joungyoun Kim, Eun-A Choi, Jay J. Shen, Scott Lee, Ji Won Yoo, Nicole Jeong, Hyung-Jin Hyun
Publikováno v:
Clinical Lung Cancer. 21:e551-e559
Metformin is the first option in managing type 2 diabetes mellitus (DM) and has pleotropic effects. We studied the incidence of lung cancer in patients who received metformin therapy.This study was retrospectively designed and based on the Korean Nat
Autor:
Melissa L. New, Anna E. Barón, Erin A. Hirsch, Peter B. Sachs, Stephanie L. Brown, Stephen P. Malkoski
Publikováno v:
Clin Lung Cancer
Background Lung cancer screening (LCS) implementation is complicated by the Centers for Medicare and Medicaid Services reimbursement requirements of shared decision-making and tobacco cessation counseling. LCS programs can utilize different structure
Causes of Death and Hospitalization in Long-term Lung Cancer Survivors: A Population-based Appraisal
Autor:
Betty Ferrell, Geena X. Wu, Dan J. Raz, Virginia Sun, Jae Y. Kim, Philip H.G. Ituarte, Loretta Erhunmwunsee
Publikováno v:
Clinical Lung Cancer. 21:204-213
Introduction Lung cancer survivorship is emerging as an important topic owing to improved survival, but information about health issues among survivors of lung cancer is still lacking. This study used a population dataset to assess causes of death (C
Autor:
Anne C. Melzer, Ping Yang, Pamala A. Jacobson, Camille Robichaux, Abbie Begnaud, Robert A. Kratzke, Constantin F. Aliferis, Nathan Rubin
Publikováno v:
Clin Lung Cancer
American Indians and Alaska Natives experience higher lung cancer mortality than other races in Minnesota. We compared rates of standard-of-care genetic mutation testing in this group compared to non-Native controls. No significant difference was ide
Publikováno v:
Clinical Lung Cancer. 21:195-203
Retrospective studies have shown an increased risk of second primary lung cancer in patients with a history of head and neck cancer (HNC). No population-based study has examined the overall survival (OS) outcomes of patients with second primary non-s
Publikováno v:
Clinical Lung Cancer. 20:429-434
Background Smoking is a major risk factor for lung cancer (LC) and transitional cell carcinoma of the bladder (TCC). Current recommendations for LC screening do not include TCC as a risk factor for determining screening eligibility. In this study we
Autor:
Benjamin Solomon, Gavin M. Wright, Peter F. M. Choong, Matthew Conron, Prudence A. Russell, Zoe Wainer, Marissa Daniels, Karla Gough, David Ball
Publikováno v:
Clinical Lung Cancer. 19:e933-e944
Introduction: Non–small-cell lung cancer (NSCLC) has disproportionately negative outcomes in men compared with women. The importance of the relationship between sex and tumor, node, metastases (TNM) staging system remains unknown. The objective of